Concepedia

Guido Achermann

GA

2

Publications

91

Citations

2

H-Index

2009

Active since

Affiliations

Roche (Switzerland)(Current)

Guido Achermann is an author at Roche (Switzerland) specializing in neuropharmacology, molecular pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyNeuropharmacologyMolecular PharmacologyNeuroscienceNeurochemistryMedicinal ChemistryCognitive Dysfunction

Publications per year

2009–2009

2

Publications

2

The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA α5 inverse agonists for the treatment of cognitive dysfunction

Henner Knust, Guido Achermann, Theresa M. Ballard et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 63 citations · Full text

Molecular Pharmacology, Medicine, Cognitive Dysfunction +8

Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABAA α5 inverse agonist series

Guido Achermann, Theresa M. Ballard, Francesca Blasco et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +6

Rows per page

1–2 of 2